BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17608262)

  • 1. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients.
    García-Galiano D; Sánchez-Garrido MA; Espejo I; Montero JL; Costán G; Marchal T; Membrives A; Gallardo-Valverde JM; Muñoz-Castañeda JR; Arévalo E; De la Mata M; Muntané J
    Obes Surg; 2007 Apr; 17(4):493-503. PubMed ID: 17608262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.
    Paredes-Turrubiarte G; González-Chávez A; Pérez-Tamayo R; Salazar-Vázquez BY; Hernández VS; Garibay-Nieto N; Fragoso JM; Escobedo G
    Clin Exp Med; 2016 May; 16(2):193-202. PubMed ID: 25894568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
    Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
    Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
    Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.
    Huang HL; Lin WY; Lee LT; Wang HH; Lee WJ; Huang KC
    Obes Surg; 2007 Nov; 17(11):1457-63. PubMed ID: 18219772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity.
    Sepúlveda-Flores RN; Vera-Cabrera L; Flores-Gutiérrez JP; Maldonado-Garza H; Salinas-Garza R; Zorrilla-Blanco P; Bosques-Padilla FJ
    Ann Hepatol; 2002; 1(1):36-9. PubMed ID: 15114294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
    Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
    Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.
    Ma H; Gomez V; Lu L; Yang X; Wu X; Xiao SY
    J Gastroenterol Hepatol; 2009 Feb; 24(2):233-7. PubMed ID: 18713296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.
    Younossi ZM; Gorreta F; Ong JP; Schlauch K; Del Giacco L; Elariny H; Van Meter A; Younoszai A; Goodman Z; Baranova A; Christensen A; Grant G; Chandhoke V
    Liver Int; 2005 Aug; 25(4):760-71. PubMed ID: 15998427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.
    Sabaté JM; Jouët P; Harnois F; Mechler C; Msika S; Grossin M; Coffin B
    Obes Surg; 2008 Apr; 18(4):371-7. PubMed ID: 18286348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines and cytokines in non-alcoholic fatty liver disease.
    Jarrar MH; Baranova A; Collantes R; Ranard B; Stepanova M; Bennett C; Fang Y; Elariny H; Goodman Z; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2008 Mar; 27(5):412-21. PubMed ID: 18081738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
    PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans.
    Pihlajamäki J; Kuulasmaa T; Kaminska D; Simonen M; Kärjä V; Grönlund S; Käkelä P; Pääkkönen M; Kainulainen S; Punnonen K; Kuusisto J; Gylling H; Laakso M
    J Hepatol; 2012 Mar; 56(3):663-70. PubMed ID: 22027586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.